Last reviewed · How we verify
Procalamine (lysine acetate)
At a glance
| Generic name | lysine acetate |
|---|---|
| Drug class | Amino Acid [EPC] |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
- Metabolic acidosis
- Alkalosis
- Osmotic diuresis and dehydration
- Rebound hypoglycemia
- Hypo- and hyper-vitaminosis
- Pulmonary embolism due to pulmonary vascular precipitates
- Hypersensitivity reactions
- Risk of infections
- Refeeding syndrome
- Hyperglycemia or hyperosmolar hyperglycemic state
- Vein damage and thrombosis
- Hepatobiliary disorders
Key clinical trials
- Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer (PHASE2)
- 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer (PHASE1,PHASE2)
- A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients (PHASE1,PHASE2)
- Essential Amino Acids and Parkinsons Disease (PHASE1)
- Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer (PHASE1)
- NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. (PHASE1)
- A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer (PHASE1,PHASE2)
- SMART Diets for MASLD (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Procalamine CI brief — competitive landscape report
- Procalamine updates RSS · CI watch RSS
- portfolio CI